Abbott concluded with the Pentagon $35-million the development contract of diagnostic aids of ChMT

On February 28, 2019 the American Ministry of Defence signed the development contract of instruments of the emergency diagnosis of the craniocereberal injuries (CI) with Abbott Laboratories.

Abbott Laboratories was the only participant of the tender with the fixed price of $35.2 million. The agreement which the Pentagon signed with the American producer of the medical equipment is calculated till August 31, 2022.

Under the terms of the agreement, the Ministry of Defence will provide to Abbott Laboratories about $12 million for research and development, testing and carrying out field tests of technologies of diagnosis of craniocereberal injuries at once. Money is selected for 2019 financial year.^[1]

Abbott concluded with the Pentagon $35-million the development contract of diagnostic aids of craniocereberal injuries

Diagnosis of a craniocereberal injury, refining of its weight and character require use of a complex of different methods. At the same time very important role is played by application not only instrumental methods of inspection, but also direct clinical inspection of the victim right after an injury, his dynamic observation. It is connected with the fact that the status of the patient who had a brain injury can quickly change, first of all at development of symptoms of a compression of a brain.

In a case with the military personnel operational diagnostics is complicated by the fact that they can be far from the medical centers with the hi-tech equipment. Abbott will have to create field set for the emergency detection of a craniocereberal injury.

Earlier the Pentagon paid Abbott of nearly $20 million for studying of the biomarkers allowing to reveal moderate ChMT. Then these biomarkers were involved in creation of the test for the portable analyzer of express diagnostics of critical conditions Abbott i-Stat which is widely used by the American military.

Notes